Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
October 28, 1998
Pharmacological analysis of cyclooxygenase-1 in inflammation
C J Smith, Y Zhang, C M Koboldt, et al.
Cancer Research
|
November 4, 2000
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats
C J Grubbs, R A Lubet, A T Koki, et al.
Cancer Research
|
December 3, 1999
Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder
S I Mohammed, D W Knapp, D G Bostwick, et al.
Cancer Research
|
May 27, 1999
Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation
P Michaluart, J L Masferrer, A M Carothers, et al.
Cancer Research
|
March 23, 2000
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
J L Masferrer, K M Leahy, A T Koki, et al.
Cancer Research
|
March 10, 1999
Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer
O N Tucker, A J Dannenberg, E K Yang, et al.
Medicinal Research Reviews
|
May 8, 1999
4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)
J J Talley, S R Bertenshaw, D L Brown, et al.
Cancer Research
|
March 10, 1999
Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
G Chan, J O Boyle, E K Yang, et al.
Journal of Medicinal Chemistry
|
March 15, 2000
4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2
J J Talley, D L Brown, J S Carter, et al.
Journal of Medicinal Chemistry
|
April 26, 1996
Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents
J J Li, M B Norton, E J Reinhard, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Proceedings of the National Academy of Sciences of the United States of America
|
October 28, 1998
Pharmacological analysis of cyclooxygenase-1 in inflammation
C J Smith, Y Zhang, C M Koboldt, et al.
Cancer Research
|
November 4, 2000
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats
C J Grubbs, R A Lubet, A T Koki, et al.
Cancer Research
|
December 3, 1999
Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder
S I Mohammed, D W Knapp, D G Bostwick, et al.
Cancer Research
|
May 27, 1999
Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation
P Michaluart, J L Masferrer, A M Carothers, et al.
Cancer Research
|
March 23, 2000
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
J L Masferrer, K M Leahy, A T Koki, et al.
Cancer Research
|
March 10, 1999
Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer
O N Tucker, A J Dannenberg, E K Yang, et al.
Medicinal Research Reviews
|
May 8, 1999
4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)
J J Talley, S R Bertenshaw, D L Brown, et al.
Cancer Research
|
March 10, 1999
Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
G Chan, J O Boyle, E K Yang, et al.
Journal of Medicinal Chemistry
|
March 15, 2000
4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2
J J Talley, D L Brown, J S Carter, et al.
Journal of Medicinal Chemistry
|
April 26, 1996
Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents
J J Li, M B Norton, E J Reinhard, et al.
Page
of 6